GlassScriptPhysician profile
Roger Lee Tolar
NPI 1255365276
$17,040.60
in general payments reported to CMS, 2019-2025
64 companies · $2,629 in 2025
The $2,629 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,057 · 2020: $1,720 · 2021: $2,368 · 2022: $3,385 · 2023: $2,857 · 2024: $2,025 · 2025: $2,629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,510.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,891.16 | 2022 | |
| Abbvie INC. | $1,630.70 | 2019-2025 | Qulipta, Ubrelvy, Vraylar |
| Astrazeneca Pharmaceuticals LP | $1,276.06 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $1,271.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $983.00 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $637.39 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $628.30 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $576.30 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Amarin Pharma, INC. | $519.57 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $489.21 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Antares Pharma, INC. | $470.73 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Allergan, INC. | $468.89 | 2019-2020 | |
| Tris Pharma INC | $432.35 | 2019-2025 | Dyanavel Xr |
| Janssen Pharmaceuticals, INC | $420.15 | 2019-2025 | Xarelto, Spravato |
| Amgen INC. | $412.99 | 2019-2024 | Otezla, Repatha |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $378.81 | 2019-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $351.30 | 2021-2024 | |
| Corcept Therapeutics | $340.43 | 2021-2025 | Korlym |
| Biohaven Pharmaceuticals, INC. | $303.06 | 2020-2021 | |
| Astellas Pharma US INC | $264.82 | 2019-2025 | Veozah, Myrbetriq |
| Supernus Pharmaceuticals, INC. | $236.39 | 2021-2025 | Xyosted, Qelbree, Qelbree |
| Genentech USA, INC. | $215.09 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $212.09 | 2019-2024 | Jornay Pm |
| Idorsia Pharmaceuticals US INC | $199.52 | 2023 | Quviviq |
| Abbott Laboratories | $197.59 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Phathom Pharmaceuticals, INC. | $195.92 | 2024-2025 | Voquezna |
| Eisai INC. | $179.21 | 2019-2021 | |
| Halozyme INC | $155.50 | 2023 | |
| Corium, LLC | $147.72 | 2024 | Azstarys, Azstarys |
| Verity Pharmaceuticals INC. | $127.05 | 2024-2025 | Tlando, Trelstar |
| Esperion Therapeutics, INC. | $126.90 | 2023-2025 | Nexletol |
| Medtronic, INC. | $111.28 | 2021-2024 | Intellis Adaptivestim |
| Teva Pharmaceuticals USA, INC. | $94.83 | 2019-2020 | |
| Tolmar, INC. | $87.31 | 2023-2025 | Jatenzo |
| Exact Sciences Corporation | $79.39 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $73.99 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $61.58 | 2025 | Jornay Pm |
| Azurity Pharmaceuticals, INC. | $60.80 | 2024-2025 | Horizant, Alvesco |
| Dexcom, INC. | $55.86 | 2023 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.38 | 2020-2024 | Xifaxan |
| Pacira Therapeutics, INC. | $47.67 | 2019-2021 | |
| Clarus Therapeutics INC. | $46.70 | 2021 | |
| Neos Therapeutics, LP | $46.30 | 2019-2025 | Adzenys Xr-Odt |
| Inspire Medical Systems, INC. | $35.76 | 2023-2024 | Inspire |
| Xeris Pharmaceuticals, INC. | $35.57 | 2024-2025 | Recorlev, Keveyis |
| Shire North American Group INC | $34.24 | 2019 | |
| Adlon Therapeutics L.P. | $32.52 | 2019-2021 | |
| Dynavax Technologies Corporation | $30.70 | 2020-2025 | Heplisav-B |
| Acerus Pharmaceuticals Corporation | $30.28 | 2021-2022 | |
| Bausch Health US, LLC | $25.02 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $24.94 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $24.83 | 2021-2022 | |
| Lundbeck LLC | $24.09 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.79 | 2019-2021 | |
| Ibsa Pharma INC. | $20.83 | 2025 | Tirosint, Flector, Licart |
| Bioventus LLC | $20.14 | 2019 | |
| Jazz Pharmaceuticals INC. | $19.74 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.70 | 2025 | Rexulti |
| Kaleo, INC. | $17.75 | 2022 | |
| Aytu Biopharma, INC. | $15.44 | 2024 | Karbinal |
| Daiichi Sankyo INC. | $13.04 | 2019 | |
| Ironwood Pharmaceuticals, INC | $12.12 | 2020 | |
| Seqirus USA INC | $12.10 | 2022 | |
| Galderma Laboratories, L.P. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Tolar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.